Loading...
| A03173 | Pages: NA | Dec 2021 | 4922 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Eubiotics Market
Request Now !Eubiotics refers to the science of healthy living. Eubiotics ensures that a healthy balance of micro-flora is maintained in the gastrointestinal tract of an animal.
The global eubiotics market is driven by several factors such as rise in awareness about feed quality & safety, rising demand for manufactured animal feed, increasing trend of replacing antibiotic growth promoters (AGPS) with eubiotics, and growth in the demand for animal protein. However, complexities of food production chains and strict regulations for trade of eubiotics will restrain the market growth. Increasing investments in the animal nutrition sector and increase in awareness about eubiotics will provide opportunities for the market growth.
The report segments the global eubiotics market based on type, livestock, function, dosage form, and region. Based on type, it is divided into probiotics, prebiotics, organic acids, and essential oils. Based on livestock, it is segmented into poultry, swine, ruminants, and aquatic animals. Based on function, it is divided into nutrition & gut health, yield, immunity, and production. Based on dosage form, it is bifurcated into dry and liquid. Geographically, it has been analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Key players that operate in the market include Cargill, Incorporated, BASF SE, E. I. du Pont de Nemours and Company, Koninklijke DSM N.V., Novozymes, Kemin Industries, Inc., and Calpis Co., Ltd.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities
CHAPTER 4 EUBIOTICS MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. PROBIOTICS
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. PREBIOTICS
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. ORGANIC ACIDS
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
4.5. ESSENTIAL OILS
4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast
CHAPTER 5 EUBIOTICS MARKET, BY LIVESTOCK
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. POULTRY
5.2.1. Market size and forecast
5.3. SWINE
5.3.1. Market size and forecast
5.4. RUMINANTS
5.4.1. Market size and forecast
5.5. AQUATIC ANIMALS
5.5.1. Market size and forecast
CHAPTER 6 EUBIOTICS MARKET, BY FUNCTION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. NUTRITION AND GUT HEALTH
6.2.1. Market size and forecast
6.3. YIELD
6.3.1. Market size and forecast
6.4. IMMUNITY
6.4.1. Market size and forecast
6.5. PRODUCTION
6.5.1. Market size and forecast
CHAPTER 7 EUBIOTICS MARKET, BY DOSAGE FORM
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. DRY
7.2.1. Market size and forecast
7.3. LIQUID
7.3.1. Market size and forecast
CHAPTER 8 EUBIOTICS MARKET, BY REGION
8.1. OVERVIEW
8.2. NORTH AMERICA
8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast
8.2.3.1. U.S. market size and forecast
8.2.3.2. Canada market size and forecast
8.2.3.3. Mexico market size and forecast
8.2.4. North America Eubiotics Market by Type
8.2.5. North America Eubiotics Market by Livestock
8.2.6. North America Eubiotics Market by Function
8.2.7. North America Eubiotics Market by Dosage Form
8.2.8. North America Eubiotics Market by Application
8.3. EUROPE
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
8.3.3.1. Germany market size and forecast
8.3.3.2. France market size and forecast
8.3.3.3. UK market size and forecast
8.3.3.4. Italy market size and forecast
8.3.3.5. Spain market size and forecast
8.3.3.6. Rest of Europe market size and forecast
8.3.4. Europe Eubiotics Market by Type
8.3.5. Europe Eubiotics Market by Livestock
8.3.6. North America Eubiotics Market by Function
8.3.7. Europe Eubiotics Market by Dosage Form
8.3.8. Europe Eubiotics Market by Application
8.4. ASIA-PACIFIC
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
8.4.3.1. Japan market size and forecast
8.4.3.2. China market size and forecast
8.4.3.3. Australia market size and forecast
8.4.3.4. India market size and forecast
8.4.3.5. South Korea market size and forecast
8.4.3.6. Rest of Asia-Pacific market size and forecast
8.4.4. Asia-Pacific Eubiotics Market by Type
8.4.5. Asia-Pacific Eubiotics Market by Livestock
8.4.6. Asia-Pacific Eubiotics Market by Function
8.4.7. Asia-Pacific Eubiotics Market by Dosage Form
8.4.8. Asia-Pacific Eubiotics Market by Application
8.5. LAMEA
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast
8.5.3.1. Brazil market size and forecast
8.5.3.2. Saudi Arabia market size and forecast
8.5.3.3. South Africa market size and forecast
8.5.3.4. Rest of LAMEA market size and forecast
8.5.4. LAMEA Eubiotics Market by Type
8.5.5. LAMEA Eubiotics Market by Livestock
8.5.6. LAMEA Eubiotics Market by Function
8.5.7. LAMEA Eubiotics Market by Dosage Form
8.5.8. LAMEA Eubiotics Market by Application
CHAPTER 9 COMPANY PROFILES
9.1. BASF SE
9.1.1. Operating business segments
9.1.2. Business performance
9.1.3. Key strategic moves and developments
9.2. CARGILL, INC.
9.2.1. Operating business segments
9.2.2. Business performance
9.2.3. Key strategic moves and developments
9.3. E. I. DU PONT DE NEMOURS AND COMPANY
9.3.1. Operating business segments
9.3.2. Business performance
9.3.3. Key strategic moves and developments
9.4. KONINKLIJKE DSM N.V.
9.4.1. Operating business segments
9.4.2. Business performance
9.4.3. Key strategic moves and developments
9.5. CHR. HANSEN A/S
9.5.1. Operating business segments
9.5.2. Business performance
9.5.3. Key strategic moves and developments
9.6. ASAHI GROUP HOLDINGS, LTD.
9.6.1. Operating business segments
9.6.2. Business performance
9.6.3. Key strategic moves and developments
9.7. NOVOZYMES
9.7.1. Operating business segments
9.7.2. Business performance
9.7.3. Key strategic moves and developments
9.8. LESAFFRE
9.8.1. Operating business segments
9.8.2. Business performance
9.8.3. Key strategic moves and developments
9.9. LALLEMAND INC.
9.9.1. Operating business segments
9.9.2. Business performance
9.9.3. Key strategic moves and developments
9.10. KEMIN INDUSTRIES, INC.
9.10.1. Operating business segments
9.10.2. Business performance
9.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
